× HOME EDITORIAL BOARD SUBSCRIPTION ABSTRACTED CONTACT US PUBLICATION PROCESS MANUSCRIPT SUBMISSION
☰

CELECOXIB–CHALCONE HYBRIDIZATION GENERATESDUAL COX-2/FACTOR XA INHIBITORS WITHENHANCEDCOX-2 SELECTIVITY: AN In-silico DRUG DESIGN STUDY


Author: P. K. Arora, D. Kumar, S. Sharma, V. A. Sethi, G. Vaishnav
Views: 1
Downloads: 4
Citations: 0
Abstract

Anti-inflammatory selective cyclooxygenase-2 (COX-2) inhibitors have minimal gastrointestinal toxicity comparedwith non-selective NSAIDs; however, cardiovascular concerns associated with selective COX-2 inhibitors highlight the need for safer anti-inflammatory agents. This study aimed to design celecoxib-based chalcone derivatives withenhanced COX-2 selectivity and potential factor Xa inhibitory activity. Fifty derivatives were rationally designedbyintroducing an α,β-unsaturated carbonyl linker between the phenyl and pyrazole rings and subjected to in-silicoevaluation using toxicity, physicochemical, ADME, and molecular docking studies against COX-2, COX-1, andanticoagulant factor (factor Xa). Of the 50 derivatives, 45 showed stronger predicted COX-2 binding than celecoxib, with reduced COX-1 interaction, while several exhibited favourable factor Xa affinity. The study has predictedleadmolecules for the development of safer anti-inflammatory therapeutics with reduced cardiovascular risk. Thus, thepresent work contributes to the advancement of multitarget drug design strategies and supports United NationsSustainable Development Goal (SDG) 3: Good Health and Well-being

Keywords: Celecoxib Derivatives, Chalcone, COX-2 inhibitors, Factor Xa, Anticoagulant, Molecular Docking, Drug Design, Drug Discovery






SCImago Journal & Country Rank


Readers around the world